TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants November 30, 1990